Company: LENZ
Filing Date: 2025-11-05
Form Type: 8-K
Source: 0001815776-25-000069
Chunk: 1

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-11-05
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                
   Number                                                                                                                 
     99.1      Press Release, dated November 5, 2025.                                                                     
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 5, 2025

  LENZ THERAPEUTICS, INC.                                                    
  By:                          /s/ Daniel Chevallard                         
  Name:                        Daniel Chevallard                             
  Title:                       Chief Financial Officer                       
                               (Principal Financial and Accounting Officer)